<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title>Anne Vetto</title>
    <link href="styles/style.css" rel="stylesheet" type="text/css">
    <link href="https://fonts.googleapis.com/css?family=Viga" rel="stylesheet">
  </head>
  <body>
    <div class="header">
      <h1 id="publications-title">Publications</h1>
    </div>
    <ul id="publications-list">
      <li class="paper-title"><a href="https://doi.org/10.1016/j.neuron.2018.09.044" target="_blank" rel="noopener noreferrer">ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Lopez-Erauskin et al. Neuron (2018), https://doi.org/10.1016/j.neuron.2018.09.044</a> &#129504;</li>
      <div id="publications-info-paper1" class="paper-info">This paper describes that in amyotrophic lateral sclerosis (ALS) pathogenesis, toxicity, not loss of function, of ALS/FTD-linked mutant FUS drives disease and that intra-axonal protein synthesis is inhibited by ALS/FTD-causing mutants in FUS.</div>
      <li class="paper-title">Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. Parone, P.A., Da Cruz, S., Han, J.S., McAlonis-Downes, M., Vetto, A.P., Lee, S.K., Tseng, E., and Cleveland, D.W. Journal of Neuroscience (2013) Vol. 33 (11): 4657-4671.</li>
      <div id="publications-info-paper2" class="paper-info">We determined that mitochondria are not the primary contributors to the disease mechanism of fatal paralysis in ALS.</div>
      <li class="paper-title">Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Da Cruz, S., Parone, P.A., Lopes, V.S., Lillo, C., McAlonis-Downes, M., Lee, S.K., Vetto, A.P., Petrosyan, S., Marsala, M., Murphy, A.N., Williams, D.S., Spiegelman, B.M., and Cleveland, D.W. Cell</li>
      <div id="publications-info-paper3" class="paper-info">We determined that muscle is not a primary target of mutant SOD1-mediated toxicity in ALS pathogenesis, though improving muscle function throughout disease could be a palliative treatment for patients with ALS.</div>
    </ul>
  </body>
</html>
